ConductScience.org, home

Trial · NCT02915523

Adverse events720

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherNauseaGastrointestinal disordersPhase 1B: Avelumab + Entinostat (3 mg)26
otherNauseaGastrointestinal disordersPhase 1B: Avelumab + Entinostat (5 mg)68
otherNauseaGastrointestinal disordersPhase 2: Avelumab + Placebo1540
otherNauseaGastrointestinal disordersPhase 2: Avelumab + Entinostat3785
otherDiarrhoeaGastrointestinal disordersPhase 1B: Avelumab + Entinostat (3 mg)36
otherDiarrhoeaGastrointestinal disordersPhase 1B: Avelumab + Entinostat (5 mg)28
otherDiarrhoeaGastrointestinal disordersPhase 2: Avelumab + Placebo1140
otherDiarrhoeaGastrointestinal disordersPhase 2: Avelumab + Entinostat3485
otherAbdominal painGastrointestinal disordersPhase 1B: Avelumab + Entinostat (3 mg)26
otherAbdominal painGastrointestinal disordersPhase 1B: Avelumab + Entinostat (5 mg)18
otherAbdominal painGastrointestinal disordersPhase 2: Avelumab + Placebo1240
otherAbdominal painGastrointestinal disordersPhase 2: Avelumab + Entinostat2885
otherVomitingGastrointestinal disordersPhase 1B: Avelumab + Entinostat (3 mg)16
otherVomitingGastrointestinal disordersPhase 1B: Avelumab + Entinostat (5 mg)28
otherVomitingGastrointestinal disordersPhase 2: Avelumab + Placebo1140
otherVomitingGastrointestinal disordersPhase 2: Avelumab + Entinostat2385
otherConstipationGastrointestinal disordersPhase 1B: Avelumab + Entinostat (3 mg)06
otherConstipationGastrointestinal disordersPhase 1B: Avelumab + Entinostat (5 mg)48
otherConstipationGastrointestinal disordersPhase 2: Avelumab + Placebo1140
otherConstipationGastrointestinal disordersPhase 2: Avelumab + Entinostat2485

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02915523/events